Recombinant factor VIIa controlled release - AlteogenAlternative Names: FVIIa-NexP
Latest Information Update: 22 Dec 2015
At a glance
- Originator Alteogen
- Class Antihaemorrhagics; Blood coagulation factors; Coagulants
- Mechanism of Action Factor VIIa stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Haemophilia
Most Recent Events
- 22 Dec 2015 Preclinical trials in Haemophilia in South Korea (Injection)